Concerns about the potential association between certain diabetes medications and cardiovascular disease meant that in 2010 the FDA approved liraglutide on condition that Novo Nordisk conduct a post-marketing study to evaluate the drug's effect on the incidence of major cardiovascular events (Nielsen, DeChiaro, Goldman)
These pharmacies adhere to strict safety and efficacy standards, ensuring that the medications you receive are of the highest quality
Editorial Advisory Board Member, Harvard Health Publishing GLP-1 drugs for diabetes and weight loss have proven to be very effective, but they do have side effects
One is due to slowed gastric emptying
Except for oral semaglutide, theyre typically subcutaneous injections (administered into the fatty tissue just under the skin)
Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults